Company Analysis

Nuvation Bio Inc. (NUVB)

NYSE: NUVB · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2020
Grade5.4
◀ Past 6.2● Present 4.6▶ Future 5.8
2 est.

Filings

199 filings since 2017 beside 201 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 10, 2026.

Filings a yearinsider forms included
37905036696454
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Feb 12, 2025.SEC letters: 7 in the last 36 months, the newest Aug 12, 2024.
Insider forms 201

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 4, 2026 10-Q Quarterly report Sep 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Jul 6, 2026 8-K items 2.03, 8.01, 9.01 New debt or obligation taken on; Other event · Current report Jun 30, 2026
Jun 30, 2026 8-K items 1.01, 1.02, 2.03, 8.01, 9.01 Major agreement signed; Major agreement ended; New debt or obligation taken on; Other event · Current report Jun 24, 2026
Jun 29, 2026 424B5 Shelf offering
Jun 29, 2026 305B2 Form 305B2
Jun 26, 2026 FWP Offering communication
Jun 25, 2026 424B5 Shelf offering
May 27, 2026 8-K item 5.07 Shareholder vote · Current report May 21, 2026
May 4, 2026 8-K items 2.02, 9.01 Results released · Current report
May 4, 2026 10-Q Quarterly report Mar 31, 2026
Apr 21, 2026 DEFA14A Extra proxy material
Apr 10, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 10, 2026 DEF 14A Proxy statement May 21, 2026
Mar 3, 2026 S-8 Employee stock plan registration
Mar 2, 2026 10-K Annual report Dec 31, 2025
Mar 2, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 10, 2026 25-NSE Delisting notice from the exchange
Jan 12, 2026 8-K items 1.01, 2.02, 7.01, 9.01 Major agreement signed; Results released; Investor disclosure (Regulation FD) · Current report Jan 11, 2026
Nov 26, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Nov 17, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Nov 3, 2025 S-8 Employee stock plan registration
Nov 3, 2025 10-Q Quarterly report Sep 30, 2025
Nov 3, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 7, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 7, 2025 10-Q Quarterly report Jun 30, 2025
Jul 17, 2025 SCHEDULE 13G Large holder notice
Jun 11, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 23, 2025 8-K item 5.07 Shareholder vote · Current report May 21, 2025
May 12, 2025 SCHEDULE 13G/A Large holder update, amended
May 7, 2025 8-K items 2.02, 9.01 Results released · Current report
May 7, 2025 10-Q Quarterly report Mar 31, 2025
Apr 28, 2025 SCHEDULE 13G/A Large holder update, amended
Apr 8, 2025 ARS Annual report to shareholders Dec 31, 2024
Apr 8, 2025 DEF 14A Proxy statement May 21, 2025
Mar 25, 2025 8-K item 1.01 Major agreement signed · Current report Mar 21, 2025
Mar 6, 2025 S-3ASR Shelf registration
Mar 6, 2025 8-K items 2.02, 9.01 Results released · Current report
40 of 199 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton NUVB · research, not advice